Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1982 1
1983 1
1984 3
1986 1
1987 2
1988 1
1989 3
1991 2
1992 1
1996 2
1997 4
1998 3
1999 1
2000 2
2001 3
2002 1
2003 1
2005 4
2006 3
2008 1
2010 1
2011 2
2012 3
2014 4
2016 1
2017 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Simultaneous radiochemotherapy for recurrent and metastatic breast carcinoma: evaluation of two treatment concepts.
Plasswilm L, Seegenschmiedt MH, Ganssauge F, Sauer R. Plasswilm L, et al. Am J Clin Oncol. 1996 Aug;19(4):403-7. doi: 10.1097/00000421-199608000-00018. Am J Clin Oncol. 1996. PMID: 8677915 Clinical Trial.
Since October 1989, group A (28 patients) received 60 Gy "split-course" radiotherapy (RT) over 10 weeks with two breaks of 2 weeks each after the second and fourth week of RT. ...
Since October 1989, group A (28 patients) received 60 Gy "split-course" radiotherapy (RT) over 10 weeks with two breaks of 2 weeks ea …
Breast carcinoma in elderly women: pathology, prognosis, and survival.
Schaefer G, Rosen PP, Lesser ML, Kinne DW, Beattie EJ Jr. Schaefer G, et al. Pathol Annu. 1984;19 Pt 1:195-219. Pathol Annu. 1984. PMID: 6462768
Pathologic analysis revealed that some tumor types with a relatively favorable prognosis (mucinous, papillary, infiltrating lobular) occur more often in elderly women. However, this probably has little bearing on overall prognosis in the group since infiltrating duc …
Pathologic analysis revealed that some tumor types with a relatively favorable prognosis (mucinous, papillary, infiltrating lobular) …
Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
Manohar K, Mittal BR, Senthil R, Kashyap R, Bhattacharya A, Singh G. Manohar K, et al. Nucl Med Commun. 2012 Jun;33(6):591-6. doi: 10.1097/MNM.0b013e3283516716. Nucl Med Commun. 2012. PMID: 22334135
FDG PET/CT was true positive in 75 patients, false positive in six patients, true negative in 35 patients and false negative in one patient, with a sensitivity, specificity, positive predictive value and a negative predictive value of 98.7, 85.3, 92.5 and 97.2%, res …
FDG PET/CT was true positive in 75 patients, false positive in six patients, true negative in 35 patients and false negative in one patient, …
Successful management of synchronous recurrent breast carcinoma with chronic myelogenous leukemia: a case report.
Elm'hadi C, Khmamouche MR, Tanz R, Toreis M, Mahtat E, Allaoui M, Oukabli M, Messaoudi N, Errihani H, Ichou M. Elm'hadi C, et al. J Med Case Rep. 2017 Jan 10;11(1):10. doi: 10.1186/s13256-016-1180-4. J Med Case Rep. 2017. PMID: 28069070 Free PMC article.
Daily imatinib was ordered concurrently with chemotherapy-type docetaxel. The metastases were stable after nine courses of chemotherapy. Due to breast cancer progression 4 months later, bevacizumab and capecitabine were introduced. ...
Daily imatinib was ordered concurrently with chemotherapy-type docetaxel. The metastases were stable after nine courses of chemothera …
Prediction of early and late recurrence in patients with breast carcinoma.
Takeuchi H, Tsuji K, Ueo H. Takeuchi H, et al. Breast Cancer. 2005;12(3):161-5. doi: 10.2325/jbcs.12.161. Breast Cancer. 2005. PMID: 16110285 Free article.
BACKGROUND: The clinical course of patients with recurrent breast carcinoma varies greatly. Better characterization of an individual's clinical course for recurrent patients may aid in their clinical management. ...
BACKGROUND: The clinical course of patients with recurrent breast carcinoma varies greatly. Better characterization of an individual' …
Full-thickness chest wall resection for recurrent breast carcinoma: an institutional review and meta-analysis.
Pameijer CR, Smith D, McCahill LE, Bimston DN, Wagman LD, Ellenhorn JD. Pameijer CR, et al. Am Surg. 2005 Sep;71(9):711-5. Am Surg. 2005. PMID: 16468503
Locoregional recurrence of breast cancer can occur in up to 30 per cent of patients and has often been considered to indicate a poor prognosis. We reviewed our experience with full-thickness chest wall resection for recurrent breast cancer and conducted a meta-analysis of …
Locoregional recurrence of breast cancer can occur in up to 30 per cent of patients and has often been considered to indicate a poor prog …
Fine-needle aspiration cytodiagnosis of recurrent carcinoma of the breast in operative scars.
Gupta RK. Gupta RK. Diagn Cytopathol. 1997 Jan;16(1):14-6. doi: 10.1002/(sici)1097-0339(199701)16:1<14::aid-dc4>3.0.co;2-v. Diagn Cytopathol. 1997. PMID: 9034730
The remaining 52 cases on repeated FNAC were diagnosed as benign, and this was confirmed on a subsequent biopsy. The sensitivity, specificity, and predictive value for cytologic findings were 94.2, 100, and 100%, respectively. ...
The remaining 52 cases on repeated FNAC were diagnosed as benign, and this was confirmed on a subsequent biopsy. The sensitivity, specificit …
50 results